Dystroglycanopathies are a group of diseases characterized by impaired laminin-DAG1 interaction, including Walker-Warburg syndrome [48], muscle-eye-brain disease [49], and Fukuyama congenital muscular dystrophy [50]. Here, LAMB2 is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.